Erymax 250mg (Erythromycin delayed-release 250 mg)
This pill with imprint "Erymax 250mg" is Orange / Clear, Capsule-shape and has been identified as Erythromycin delayed-release 250 mg. It is supplied by Midlothian Laboratories.
Erythromycin is used in the treatment of dental abscess; skin or soft tissue infection; upper respiratory tract infection; bronchitis; bowel preparation (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Erythromycin delayed-release
- Imprint:
- Erymax 250mg
- Strength:
- 250 mg
- Color:
- Orange / Clear
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Macrolides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Midlothian Laboratories
- National Drug Code (NDC):
- 68308-0250
More about erythromycin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 25 Reviews – Add your own review/rating
- Drug class: macrolides
Consumer resources
- Erythromycin
- Erythromycin Tablets
- Erythromycin Delayed-Release Tablets and Capsules
- Erythromycin Ethylsuccinate Suspension
- Erythromycin Lactobionate
- ... +2 more
Other brands: Erythrocin, Ery-Tab, Eryc, Erythrocin Stearate Filmtab, ... +6 more
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
